FindTrial
Sign In

Stapokibart

BIOLOGICAL6 trials

Sponsors

Keymed Biosciences Co.Ltd, Beijing Tongren Hospital, First Affiliated Hospital of Chongqing Medical University, Chengdu Kangnuoxing Biopharma,Inc.

Conditions

Atopic Dermatitis (AD)Biological TherapyBiomarkersCRSWNPChronic Rhinosinusitis with Nasal Polyps (CRSwNP)Primary Cutaneous AmyloidosisPrurigo NodularisSAR

Phase 3

Study on the Treatment of Prurigo Nodularis With Stapokibart Injection
Active, not recruitingNCT06424470
Keymed Biosciences Co.LtdPrurigo Nodularis
Start: 2024-06-25End: 2026-07-30Updated: 2025-05-22

Phase 4

A Cohort Study on Biomarkers to Predict the Efficacy of Biologics for Chronic Rhinosinusitis with Nasal Polyps
Not yet recruitingNCT06801353
Beijing Tongren HospitalBiological Therapy, Biomarkers, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Start: 2025-02-01End: 2026-07-01Target: 90Updated: 2025-02-06

Unknown Phase

Efficacy and Safety of Stapokibart for Primary Cutaneous Amyloidosis
Not yet recruitingNCT07143864
First Affiliated Hospital of Chongqing Medical UniversityPrimary Cutaneous Amyloidosis
Start: 2025-09-15End: 2026-12-31Target: 40Updated: 2025-08-27
A Prospective Study of Stapokibart Injection in Patients With Seasonal Allergic Rhinitis (SAR)
Not yet recruitingNCT07459556
Chengdu Kangnuoxing Biopharma,Inc.SAR
Start: 2026-03-01End: 2028-02-01Target: 400Updated: 2026-03-09
A Study of Stapokibart Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) .
Not yet recruitingNCT07483268
Chengdu Kangnuoxing Biopharma,Inc.CRSWNP
Start: 2026-06-01End: 2028-02-01Target: 600Updated: 2026-03-19
A Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD)
Not yet recruitingNCT07544862
Chengdu Kangnuoxing Biopharma,Inc.Atopic Dermatitis (AD)
Start: 2026-06-01End: 2028-02-01Target: 1000Updated: 2026-04-22